Computational pipeline for personalised cancer vaccine design
16 October 2024 | By
Ludwig Cancer Research researchers have designed and validated a computational pipeline which integrates molecular and genetic analyses.
List view / Grid view
16 October 2024 | By
Ludwig Cancer Research researchers have designed and validated a computational pipeline which integrates molecular and genetic analyses.
Biolojic Design is redefining antibody therapies by creating “programmable” antibodies that intelligently target well-validated autoimmune and oncology pathways. In this Q&A, CEO and founder Yanay Ofran, PhD, describes Biolojic’s groundbreaking approach, which leverages AI and machine learning to design antibodies capable of adjusting their behaviour based on their biological environment.…
In this Q&A, Curve Therapeutic’s Chief Scientific Officer Professor Ali Tavassoli discusses how dual HIF inhibition could combat solid tumours.
Researchers highlight the need for considering biomarkers alongside other health outcomes, as well as the need for omic data standardisation.
Researchers have created dual-targeted CARs, which performed better than single-targeted CARs in both in vivo and in vitro experiments.
Researchers have developed a computational analysis tool which will improve patient stratification and enable personalised medicine.
A new blood panel test reports the tumour fraction and the tumour type of prostate cancer with a high level of accuracy.
An advanced computational model enables scientists to study how cancer cells navigate through blood vessels.
Novel findings about the tafazzin gene offers a potential new target and drug candidate for Barth syndrome.
Analysis of cells shows many regions in DNA are differentially activated or inactivated in a cancer-specific manner.
New open-source computational method called Spectra improves analysis of single-cell transcriptomic data.
A study out of Japan reveals diversity of protein structures and how they fold in nature, uncovering a myriad of protein topologies.